{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:27:19Z","timestamp":1772166439045,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Subthalamic deep brain stimulation (STN-DBS) effectively treats motor symptoms in appropriately selected patients with Parkinson\u2019s disease, but individual responses vary. Despite modern directional leads allowing more precise stimulation, optimal contact selection strategies have not yet been standardized. This study compares a standardized imaging-guided contact selection protocol to conventional clinical programming.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We designed a monocentric, randomized, double-blind crossover trial enrolling 30 people with Parkinson\u2019s disease with bilateral directional STN-DBS. Participants will undergo both programming approaches: standardized imaging-guided contact selection targeting the dorsolateral STN and conventional contact selection through clinical test stimulations. Each configuration will be applied for 1 week. The primary outcome is patient preference after both treatments. Secondary outcomes include motor assessments (MDS-UPDRS III), accelerometric monitoring, and questionnaire-based quality of life measures (e.g., PDQ-39).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study addresses a critical gap in standardization of imaging-guided DBS programming. By using patient preference as the primary outcome, we aim to capture clinically meaningful differences that may not be detected with traditional motor scales. The crossover design balances statistical power with clinical feasibility in specialized care settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Deutsches Register f\u00fcr Klinische Studien DRKS00034229. Registered on May 27, 2024.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09396-3","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:05:59Z","timestamp":1767135959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative evaluation of standardized imaging-guided contact selection for subthalamic deep brain stimulation in Parkinson\u2019s disease: study protocol for a randomized double-blind crossover trial"],"prefix":"10.1186","volume":"27","author":[{"given":"G. A.","family":"Brandt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Piotrowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. N.","family":"Petry-Schmelzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schedlich-Teufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Visser-Vandewalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A.","family":"Dembek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. T.","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"issue":"3","key":"9396_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1212\/WNL.51.3.850","volume":"51","author":"R Kumar","year":"1998","unstructured":"Kumar R, Lozano AM, Kim YJ, Hutchison WD, Sime E, Halket E, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson\u2019s disease. Neurology. 1998;51(3):850\u20135.","journal-title":"Neurology"},{"issue":"9","key":"9396_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa060281","volume":"355","author":"G Deuschl","year":"2006","unstructured":"Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Sch\u00e4fer H, B\u00f6tzel K, et al. A randomized trial of deep-brain stimulation for Parkinson\u2019s disease. N Engl J Med. 2006;355(9):896\u2013908.","journal-title":"N Engl J Med"},{"issue":"3","key":"9396_CR3","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1212\/WNL.0000000000012246","volume":"97","author":"F Bove","year":"2021","unstructured":"Bove F, Mulas D, Cavallieri F, Castrioto A, Chabard\u00e8s S, Meoni S, et al. Long-term outcomes (15 years) after subthalamic nucleus deep brain stimulation in patients with Parkinson disease. Neurology. 2021;97(3):e254\u201362.","journal-title":"Neurology"},{"issue":"1","key":"9396_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41531-021-00223-5","volume":"7","author":"ML Lachenmayer","year":"2021","unstructured":"Lachenmayer ML, M\u00fcrset M, Antih N, Debove I, Muellner J, Bompart M, et al. Subthalamic and pallidal deep brain stimulation for Parkinson\u2019s disease-meta-analysis of outcomes. NPJ Park Dis. 2021;7(1):77.","journal-title":"NPJ Park Dis"},{"key":"9396_CR5","doi-asserted-by":"crossref","unstructured":"Ellis TM, Foote KD, Fernandez HH, Sudhyadhom A, Rodriguez RL, Zeilman P, et al. Reoperation for suboptimal outcomes after deep brain stimulation surgery. Neurosurgery. 2008;63(4):754\u201360; discussion 760\u2013761.","DOI":"10.1227\/01.NEU.0000325492.58799.35"},{"key":"9396_CR6","doi-asserted-by":"crossref","unstructured":"Hamani C, Florence G, Heinsen H, Plantinga BR, Temel Y, Uludag K, et al. Subthalamic nucleus deep brain stimulation: basic concepts and novel perspectives. eNeuro. 2017 [cited 2022 Oct 26];4(5). Available from: https:\/\/www.eneuro.org\/content\/4\/5\/ENEURO.0140-17.2017.","DOI":"10.1523\/ENEURO.0140-17.2017"},{"issue":"9","key":"9396_CR7","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/mds.20056","volume":"19","author":"J Herzog","year":"2004","unstructured":"Herzog J, Fietzek U, Hamel W, Morsnowski A, Steigerwald F, Schrader B, et al. Most effective stimulation site in subthalamic deep brain stimulation for Parkinson\u2019s disease. Mov Disord. 2004;19(9):1050\u20134.","journal-title":"Mov Disord"},{"issue":"7","key":"9396_CR8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/mds.25006","volume":"27","author":"F Wodarg","year":"2012","unstructured":"Wodarg F, Herzog J, Reese R, Falk D, Pinsker MO, Steigerwald F, et al. Stimulation site within the MRI-defined STN predicts postoperative motor outcome. Mov Disord. 2012;27(7):874\u20139.","journal-title":"Mov Disord"},{"issue":"4","key":"9396_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/ana.25567","volume":"86","author":"TA Dembek","year":"2019","unstructured":"Dembek TA, Roediger J, Horn A, Reker P, Oehrn C, Dafsari HS, et al. Probabilistic sweet spots predict motor outcome for deep brain stimulation in Parkinson disease. Ann Neurol. 2019;86(4):527\u201338.","journal-title":"Ann Neurol"},{"issue":"158","key":"9396_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neuroimage.2017.07.012","volume":"1","author":"H Akram","year":"2017","unstructured":"Akram H, Sotiropoulos SN, Jbabdi S, Georgiev D, Mahlknecht P, Hyam J, et al. Subthalamic deep brain stimulation sweet spots and hyperdirect cortical connectivity in Parkinson\u2019s disease. Neuroimage. 2017;158:332\u201345.","journal-title":"Neuroimage"},{"issue":"8","key":"9396_CR11","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/mds.26669","volume":"31","author":"F Steigerwald","year":"2016","unstructured":"Steigerwald F, M\u00fcller L, Johannes S, Matthies C, Volkmann J. Directional deep brain stimulation of the subthalamic nucleus: a pilot study using a novel neurostimulation device. Mov Disord. 2016;31(8):1240\u20133.","journal-title":"Mov Disord"},{"issue":"10","key":"9396_CR12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/mds.27093","volume":"32","author":"TA Dembek","year":"2017","unstructured":"Dembek TA, Reker P, Visser-Vandewalle V, Wirths J, Treuer H, Klehr M, et al. Directional DBS increases side-effect thresholds-a prospective, double-blind trial. Mov Disord. 2017;32(10):1380\u20138.","journal-title":"Mov Disord"},{"issue":"2","key":"9396_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41582-020-00426-z","volume":"17","author":"JK Krauss","year":"2021","unstructured":"Krauss JK, Lipsman N, Aziz T, Boutet A, Brown P, Chang JW, et al. Technology of deep brain stimulation: current status and future directions. Nat Rev Neurol. 2021;17(2):75\u201387.","journal-title":"Nat Rev Neurol"},{"issue":"S3","key":"9396_CR14","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1002\/mds.10162","volume":"17","author":"J Volkmann","year":"2002","unstructured":"Volkmann J, Herzog J, Kopper F, Deuschl G. Introduction to the programming of deep brain stimulators. Mov Disord. 2002;17(S3):S181\u20137.","journal-title":"Mov Disord"},{"issue":"3","key":"9396_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.brs.2016.02.004","volume":"9","author":"M Picillo","year":"2016","unstructured":"Picillo M, Lozano AM, Kou N, Puppi Munhoz R, Fasano A. Programming deep brain stimulation for Parkinson\u2019s disease: the Toronto Western Hospital algorithms. Brain Stimul. 2016;9(3):425\u201337.","journal-title":"Brain Stimul"},{"issue":"8","key":"9396_CR16","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/archneur.62.8.noc40425","volume":"62","author":"MS Okun","year":"2005","unstructured":"Okun MS, Tagliati M, Pourfar M, Fernandez HH, Rodriguez RL, Alterman RL, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol. 2005;62(8):1250\u20135.","journal-title":"Arch Neurol"},{"issue":"5","key":"9396_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1212\/WNL.59.5.706","volume":"59","author":"E Moro","year":"2002","unstructured":"Moro E, Esselink RJA, Xie J, Hommel M, Benabid AL, Pollak P. The impact on Parkinson\u2019s disease of electrical parameter settings in STN stimulation. Neurology. 2002;59(5):706\u201313.","journal-title":"Neurology"},{"key":"9396_CR18","doi-asserted-by":"publisher","unstructured":"Neudorfer C, Butenko K, Oxenford S, Rajamani N, Achtzehn J, Goede L, et al. Lead-DBS v3.0: mapping deep brain stimulation effects to local anatomy and global networks. NeuroImage. 2023;268:119862. https:\/\/doi.org\/10.1016\/j.neuroimage.2023.119862.","DOI":"10.1016\/j.neuroimage.2023.119862"},{"key":"9396_CR19","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.wneu.2019.09.106","volume":"134","author":"N Pavese","year":"2020","unstructured":"Pavese N, Tai YF, Yousif N, Nandi D, Bain PG. Traditional trial and error versus neuroanatomic 3-dimensional image software-assisted deep brain stimulation programming in patients with Parkinson disease. World Neurosurg. 2020;134:e98-102.","journal-title":"World Neurosurg"},{"key":"9396_CR20","doi-asserted-by":"crossref","unstructured":"Lange F, Steigerwald F, Malzacher T, Brandt GA, Odorfer TM, Roothans J, et al. Reduced programming time and strong symptom control even in chronic course through imaging-based DBS programming. Front Neurol. 2021 [cited 2022 Nov 14];12. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.785529.","DOI":"10.3389\/fneur.2021.785529"},{"issue":"5","key":"9396_CR21","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.brs.2021.07.064","volume":"14","author":"J Waldthaler","year":"2021","unstructured":"Waldthaler J, Bopp M, K\u00fchn N, Bacara B, Keuler M, Gjorgjevski M, et al. Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease. Brain Stimul. 2021;14(5):1109\u201317.","journal-title":"Brain Stimul"},{"key":"9396_CR22","doi-asserted-by":"publisher","first-page":"105346","DOI":"10.1016\/j.parkreldis.2023.105346","volume":"109","author":"G Duffley","year":"2023","unstructured":"Duffley G, Szabo A, Lutz BJ, Mahoney-Rafferty EC, Hess CW, Ramirez-Zamora A, et al. Interactive mobile application for Parkinson\u2019s disease deep brain stimulation (MAP DBS): an open-label, multicenter, randomized, controlled clinical trial. Parkinsonism Relat Disord. 2023;109:105346.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"9396_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200326","volume":"14","author":"M Aubignat","year":"2024","unstructured":"Aubignat M, Berro A, Tir M, Lefranc M. Imaging-guided subthalamic nucleus deep brain stimulation programming for Parkinson disease: a real-life pilot study. Neurol Clin Pract. 2024;14(6):e200326.","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"9396_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3233\/JPD-230200","volume":"14","author":"GA Brandt","year":"2024","unstructured":"Brandt GA, Stopic V, van der Linden C, Strelow JN, Petry-Schmelzer JN, Baldermann JC, et al. A retrospective comparison of multiple approaches to anatomically informed contact selection in subthalamic deep brain stimulation for Parkinson\u2019s disease. J Parkinsons Dis. 2024;14(3):575\u201387.","journal-title":"J Parkinsons Dis"},{"key":"9396_CR25","doi-asserted-by":"crossref","unstructured":"Barbe MT, Reker P, Hamacher S, Franklin J, Kraus D, Dembek TA, et al. DBS of the PSA and the VIM in essential tremor: a randomized, double-blind, crossover trial. Neurology. 2018 [cited 2025 Aug 29];91(6). Available from: https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000005956.","DOI":"10.1212\/WNL.0000000000005956"},{"issue":"1","key":"9396_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41531-024-00812-0","volume":"10","author":"A Gharabaghi","year":"2024","unstructured":"Gharabaghi A, Cebi I, Leavitt D, Scherer M, Bookjans P, Brunnett B, et al. Randomized crossover trial on motor and non-motor outcome of directional deep brain stimulation in Parkinson\u2019s disease. Npj Park Dis. 2024;10(1):204.","journal-title":"Npj Park Dis"},{"issue":"12","key":"9396_CR27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"issue":"1","key":"9396_CR28","first-page":"9","volume":"30","author":"RJ Prescott","year":"1981","unstructured":"Prescott RJ. The comparison of success rates in cross-over trials in the presence of an order effect. J R Stat Soc Ser C Appl Stat. 1981;30(1):9\u201315.","journal-title":"J R Stat Soc Ser C Appl Stat"},{"issue":"346","key":"9396_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"8","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"issue":"20","key":"9396_CR30","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa035275","volume":"349","author":"P Krack","year":"2003","unstructured":"Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease. N Engl J Med. 2003;349(20):1925\u201334.","journal-title":"N Engl J Med"},{"issue":"7","key":"9396_CR31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1205158","volume":"368","author":"WMM Schuepbach","year":"2013","unstructured":"Schuepbach WMM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson\u2019s disease with early motor complications. N Engl J Med. 2013;368(7):610\u201322.","journal-title":"N Engl J Med"},{"issue":"15","key":"9396_CR32","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129\u201370.","journal-title":"Mov Disord"},{"issue":"4","key":"9396_CR33","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","volume":"15","author":"HT Benamer","year":"2000","unstructured":"Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG. Correlation of Parkinson\u2019s disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord Off J Mov Disord Soc. 2000;15(4):692\u20138.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"9396_CR34","volume":"2014","author":"RA Hauser","year":"2014","unstructured":"Hauser RA, Gordon MF, Mizuno Y, Poewe W, Barone P, Schapira AH, et al. Minimal clinically important difference in Parkinson\u2019s disease as assessed in pivotal trials of pramipexole extended release. Park Dis. 2014;2014:467131.","journal-title":"Park Dis"},{"key":"9396_CR35","volume":"2013","author":"S Skodda","year":"2013","unstructured":"Skodda S, Gr\u00f6nheit W, Mancinelli N, Schlegel U. Progression of voice and speech impairment in the course of Parkinson\u2019s disease: a longitudinal study. Park Dis. 2013;2013:389195.","journal-title":"Park Dis"},{"issue":"1","key":"9396_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1212\/WNL.0b013e318203e7d0","volume":"76","author":"E Tripoliti","year":"2011","unstructured":"Tripoliti E, Zrinzo L, Martinez-Torres I, Frost E, Pinto S, Foltynie T, et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology. 2011;76(1):80\u20136.","journal-title":"Neurology"},{"key":"9396_CR37","doi-asserted-by":"publisher","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. Routledge; 2013. p. 656.\u00a0https:\/\/doi.org\/10.4324\/9780203771587.","DOI":"10.4324\/9780203771587"},{"key":"9396_CR38","unstructured":"Dallapiazza RF, De Vloo P, Fomenko A, Lee DJ, Hamani C, Munhoz RP, et al. Considerations for patient and target selection in deep brain stimulation surgery for Parkinson\u2019s disease. In: Stoker TB, Greenland JC, editors. Parkinson\u2019s disease: pathogenesis and clinical aspects. Brisbane (AU): Codon Publications; 2018 [cited 2025 Aug 29]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536714\/."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09396-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09396-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09396-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:25:56Z","timestamp":1769516756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09396-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9396"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09396-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6542345\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study has been obtained from the Ethics Committee of the Medical Faculty of the University of Cologne (reference number 23-1367). Written, informed consent to participate will be obtained from all participants prior to enrollment in the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable. This manuscript does not contain individual person\u2019s data, images, or videos. A model consent form for study participation is available upon request from the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"GAB received honoraria for advisory board participation unrelated to this work and travel expenses for educational activities from Boston Scientific and Medtronic GmbH. LP has nothing to declare. JNPS was supported by the Cologne Clinician Scientist Program (CCSP, Faculty of Medicine, University of Cologne), funded by the German Research Foundation (DFG, FI 773\/15-1) unrelated to this project. CvdL was supported by the DFG (Project Number 502436811), unrelated to this project, and by the CCSP. CST received personal funding from Medtronic GmbH. VVV received honoraria for advisory board participation and speaker fees from Boston Scientific, Medtronic, and LivaNova. TAD\u2019s work was supported by the CCSP. He additionally received speaker honoraria from Boston Scientific and Medtronic GmbH unrelated to this work. MTB received speaker\u2019s honoraria from Medtronic GmbH, Boston Scientific, Abbott (formerly St Jude), GE Medical, UCB, Apothekerverband K\u00f6ln eV, and Bial; research funding from the Felgenhauer-Stiftung, Forschungspool Klinische Studien (University of Cologne), Horizon 2020 (Gondola), Medtronic (ODIS), and Boston Scientific; and advisory honoraria for the Institut f\u00fcr Qualitaet und Wirtschaftlichkeit im Gesundheitswesen.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"89"}}